UPDATE - Canaccord Genuity Downgraded Dolby Laboratories (DLB) to Hold; Another Negative Surprise
Get Alerts DLB Hot Sheet
Price: $65.27 +1.68%
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 5 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UPDATE - Canaccord Genuity downgraded Dolby Laboratories (NYSE: DLB) from Buy to Hold. PT lowered from $69 to $54.
Canaccord analyst says, "We are lowering our recommendation and our target following Dolby’s FQ2/11 results. Though Broadcast and Mobile are outperforming, Cinema is experiencing headwinds and PC unit weakness lingers. Expectations for single-digit revenue and earnings growth warrant a lower valuation multiple, in our view."
To see all upgrades/downgrades on shares of DLB, visit our Analyst Ratings page.
Canaccord analyst says, "We are lowering our recommendation and our target following Dolby’s FQ2/11 results. Though Broadcast and Mobile are outperforming, Cinema is experiencing headwinds and PC unit weakness lingers. Expectations for single-digit revenue and earnings growth warrant a lower valuation multiple, in our view."
To see all upgrades/downgrades on shares of DLB, visit our Analyst Ratings page.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Create E-mail Alert Related Categories
DowngradesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share